Working… Menu

Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03315104
Recruitment Status : Completed
First Posted : October 19, 2017
Last Update Posted : July 16, 2019
Information provided by (Responsible Party):
Emergent BioSolutions

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 17, 2019
Actual Study Completion Date : June 17, 2019